Pfizer (NY: PFE )

28.85 -0.47 (-1.60%)
Official Closing Price Updated: 4:10 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,744,392
Open 29.63
Bid (Size) 28.84 (9)
Ask (Size) 28.85 (18)
Prev. Close 29.32
Today's Range 28.74 - 29.81
52wk Range 25.20 - 37.19
Shares Outstanding 5,606,688,356
Dividend Yield 5.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Warren Buffett's Approach To Investing In Election Years
Warren Buffett, known as the 'Oracle of Omaha', is a highly successful American investor who manages his portfolio consistently, regardless of elections or market conditions. 
Via Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows
Via Investor Brand Network

Performance

YTD
-2.96%
-2.96%
1 Month
+3.29%
+3.29%
3 Month
+3.89%
+3.89%
6 Month
+4.91%
+4.91%
1 Year
-19.14%
-19.14%

More News

Read More
Forget Tech! 3 Value Stocks That Could Win Big From Rate Cuts.
Via InvestorPlace
Topics Economy
Exposures Interest Rates
3 Dividend Growth Stocks to Buy Hand Over Fist in August
Via The Motley Fool
Is Pfizer Winning Its $43 Billion Bet?
Via The Motley Fool
Lucrative Incentive for Biotechs as Global Alzheimer’s Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
Via FinancialNewsMedia
3 Cheap Stocks to Buy in August for Under $50
Via InvestorPlace
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
Via The Motley Fool
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
From FN Media Group LLC
Via GlobeNewswire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Via The Motley Fool
Volatility Spikes: 3 Low Beta Stocks To Buy
Via Talk Markets
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
Via Benzinga
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
Via Investor's Business Daily
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Via Benzinga
Exposures COVID-19
Investing $100,000 in These 7 High-Yield Dividend Stocks Could Generate Over $7,000 in Annual Passive Income
Via The Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade
Via The Motley Fool
Is This Decision by Pfizer Bad News for Eli Lilly?
Via The Motley Fool
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Via Benzinga
Exposures COVID-19
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
Via InvestorPlace
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Subdued Blue-Chip Stocks That Will Reward Patient Investors
Via InvestorPlace
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Via The Motley Fool
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
Via InvestorPlace
Phio Pharmaceuticals Announces New Chief Financial Officer
Via Newsfile
Topics Initial Public Offering
Exposures Securities Market
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.